Jilin Zixin Pharmaceutical Industrial Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jilin Zixin Pharmaceutical Industrial Co Ltd with three other
companies in this sector in China:
Hybio Pharmaceutical Co Ltd
sales of 1.25 billion Chinese Renmimbi [US$181.66 million]
of which 100%
was Medical and Pharmaceutical Manufacturing),
Chongqing Lummy Pharmaceutical Co Ltd
(1.28 billion Chinese Renmimbi [US$186.89 million]
of which 99%
was Chemical Manufacturing), and
Autobio Diagnostics Co Ltd
(1.40 billion Chinese Renmimbi [US$203.96 million]
of which 83%
Jilin Zixin Pharmaceutical Industrial Co Ltd reported sales of 1.33 billion Chinese Renmimbi (US$193.47 million)
December of 2017.
increase of 62.0%
versus 2016, when the company's sales were 819.52 million Chinese Renmimbi.